News

ÖQUASTA confirms the highest quality of the INOOlab test

Fianostics successfully participated in the 9th round of the SARS-CoV-2 antibody detection round test of ÖQUASTA (Austrian Society for Quality Assurance and Standardization of Medical Diagnostic Examinations). The COVID-19 FluoBolt™-DUO-SN antibody test on which the INOOlab™ system is based correctly identified and evaluated all samples in the round-robin test “The 9th SARS-CoV-2 antibody test round-robin was extremely successful and shows the high level of SARS-CoV-2 antibody

read more

Even mild cases of COVI D-19 can affect the function and structure of the brain

A recently released study from the University of Campinas, Sao Paulo, suggest a severe pattern of changes in how the brain communicates as well as its structure, mainly in people with anxiety and depression with long COVID syndrome. The study included 254 adults (177 women, 77 men, median age 41 years) who had mild COVID-19 a median of 82 days earlier. A total of 102 had

read more

COVID-19 remains deadlier than Influenza

In a representative study from the University of Lucerne (Switzerland), researchers compared mortality and intensive care admission rates in hospitalized Swiss patients (aged 18+) with the SARS-CoV-2 omicron variant versus influenza. The results were published in the journal Jama Network Open. A significantly higher mortality rate was found for omicron: During the first 30 days of hospitalization, the mortality rate for those suffering from omicron was

read more